Ten stocks stood firmer against a broader market bloodbath on Tuesday as investors took path from a flurry of strong earnings and corporate developments. Of the 10 stocks, two surged to new all-time highs.
Meanwhile, Wall Street’s three major indices all finished in the red, with the Nasdaq down the most by 2.04 percent. The S&P 500 followed with a 1.17 percent decline, while the Dow Jones dropped by 0.53 percent.
Indices aside, we focus on the 10 companies that stood out in Tuesday’s trading session and detail the reasons behind their gains.
To come up with the list, we considered only the stocks with a $2 billion market capitalization and more than 5 million shares in trading volume.
Stock market data. Photo by Jakub Zerdzicki on Pexels
10. Yum! Brands, Inc. (NYSE:YUM)
Yum! Brands rallied for a second day on Tuesday, jumping 7.3 percent to close at $149.55 apiece after reporting a strong earnings performance in the third quarter of the year and announcing a strategic review of the struggling Pizza Hut brand.
In an updated report, Yum! Brands, Inc. (NYSE:YUM) said it was able to grow its net income by 4 percent to $397 million from $382 million in the same period last year, as revenues increased by 8 percent to $1.98 billion from $1.83 billion year-on-year on the back of strong worldwide sales performance from Taco Bell and KFC.
Operating profit rose by 8 percent to $666 million from $619 million, while total costs and expenses increased by 9 percent to $1.3 billion from $1.2 billion.
In other developments, Yum! Brands, Inc. (NYSE:YUM) said it would review strategic options for Pizza Hut in a bid to “reach its full potential for the benefit of its franchisees, consumers, and employees and to maximize value for Yum! shareholders.”
However, it did not specify whether the review process would lead to a sale or restructuring, among other actions.
“The Pizza Hut team has been working hard to address business and category challenges; however, Pizza Hut’s performance indicates the need to take additional action to help the brand realize its full value, which may be better executed outside of Yum! Brands,” said Yum! Brands, Inc. (NYSE:YUM) CEO Chris Turner.
“To truly take advantage of the brand we’ve built and the opportunities ahead, we’ve made the decision to initiate a thorough review of strategic options,” he noted.
9. The Goodyear Tire & Rubber Company (NASDAQ:GT)
The Goodyear grew its share prices by 7.84 percent on Tuesday to close at $7.43 apiece as investors cheered restructuring efforts and progress expected to help shave off as much as $2.2 billion in debt.
In an updated report, The Goodyear Tire & Rubber Company (NASDAQ:GT) said it targets to achieve $1.5 billion in annualized run-rate benefits by the end of the year, having delivered $185 million in the third quarter alone.
Last October 31, The Goodyear Tire & Rubber Company (NASDAQ:GT) completed the previously announced $650 million sale of its chemical business following the divestment of the OTR tire business and the Dunlop brand earlier in the year.
In other news, the company announced a 6,000 percent net loss expansion in the third quarter of the year, at $2.197 billion versus only $36 million in the same period last year. Net sales were also down by 4 percent to $4.6 billion from $4.8 billion year-on-year.
8. DuPont de Nemours, Inc. (NYSE:DD)
DuPont saw its share prices jump to a new all-time high on Tuesday as investors loaded portfolios ahead of its third-quarter earnings performance and following announcements that it successfully completed the separation of its electronics business, Qnity Electronics Inc.
At intra-day trading, DuPont de Nemours, Inc. (NYSE:DD) jumped to its highest 52-week price of $37.96 before paring gains to end the day just up by 8.85 percent at $37.76 apiece.
According to the company, it is scheduled to release the results of its third quarter earnings performance before market open on Thursday, November 6.
DuPont de Nemours, Inc. (NYSE:DD) earlier provided guidance for the third quarter and full-year 2025.
In the third quarter alone, it targeted around $3.32 billion in net sales, operating EBTIDA of $875 million, and adjusted EPS of $1.15.
Meanwhile, full-year net sales were targeted at $12.85 billion, while operating EBITDA and adjusted EPS were projected at $3.36 billion and $4.40, respectively.
Also on Tuesday, DuPont de Nemours, Inc. (NYSE:DD) announced the completion of Qnity’s separation into an independent public company.
In connection with the separation, each DuPont shareholder holding two common shares received one common share of Qnity. Approximately 209 million Qnity shares were distributed in the separation.
7. Graphic Packaging Holding Company (NYSE:GPK)
Graphic Packaging snapped a five-day losing streak on Tuesday, jumping 8.88 percent to close at $17.05 apiece as investors welcomed its maintained revenue guidance for the full-year period despite a dismal earnings performance in the third quarter of the year.
In an updated report, Graphic Packaging Holding Company (NYSE:GPK) said net income dropped by 14 percent to $142 million from $165 million in the same period last year, while net sales dipped by 1 percent to $2.19 billion from $2.2 billion year-on-year.
Despite the figures, Graphic Packaging Holding Company (NYSE:GPK) maintained its net sales guidance of $8.4 billion to $8.6 billion for the full-year 2025, but lowered its outlook for adjusted EBITDA and adjusted EPS to a range of $1.40 billion to $1.45 billion, and $1.80 to $2, respectively.
“Revisions from prior guidance reflect year-to-date performance, further action to match production to orders (~$15 million), and a wider-than-normal range of potential fourth quarter outcomes. Volume and market uncertainty remain unusually high given a stretched consumer and weakened consumer confidence,” the company said.
In other developments, Graphic Packaging Holding Company (NYSE:GPK) said that its new recycled paperboard manufacturing facility in Waco, Texas, officially kicked off commercial operations ahead of schedule, with full production targeted for the next 12 to 18 months.
“Waco will be the world’s most efficient producer of recycled paperboard, with the highest quality available anywhere outside of our own Kalamazoo, Michigan facility. This marks the completion of our Vision 2025 transformation, and we now turn our full attention to our Vision 2030 priorities: innovation, execution, reaching investment grade, and returning cash to stockholders,” said President and CEO Michael Doss.
6. Navan Inc. (NASDAQ:NAVN)
Navan recovered by 9.63 percent on Tuesday to close at $18.89 apiece as investors hunted for bargains after hitting its lowest price during the intra-day trade.
During the session, Navan Inc. (NASDAQ:NAVN) fell to its lowest price of $16.01 before traders turned buyers to push its share prices higher at the close.
However, Tuesday’s closing price was markedly lower by 24 percent than its initial public offering price of $25 apiece.
Navan Inc. (NASDAQ:NAVN) debuted on the stock market last Thursday, successfully selling as much as $923 million from the issuance of more than 36.9 million shares at a price of $25 apiece.
Of the total, 30 million shares were sold by Navan Inc. (NASDAQ:NAVN), raising $750 million in fresh funds, while the remaining $123 million, covering 6.9 million shares, were sold by existing shareholders.
Navan Inc. (NASDAQ:NAVN) is an all-in-one business travel, payments, and expense management platform, offering users a streamlined experience for booking flights and hotels.
5. Liquidia Corp. (NASDAQ:LQDA)
Liquidia soared by 10.67 percent on Tuesday to close at $27.91 apiece, just 92 cents shy of its highest 52-week price, as investor sentiment was bolstered by strong demand for its pulmonary hypertension treatment.
In an updated report, Liquidia Corp. (NASDAQ:LQDA) said that total revenues in the third quarter of the year soared by 1,134 percent to $54 million from $4.4 million in the same period last year, on the back of a strong sales performance from its Yutrepia treatment.
Of the total revenues, product sales stood at $51.7 million, while service revenues ended at $2.67 million.
The strong performance helped the company narrow its net loss for the third quarter by 89 percent to $3.5 million from $31.03 million in the same comparable period.
“Our third quarter results demonstrate the continued momentum of Yutrepia’s launch and the clear enthusiasm from both prescribers and patients. As of October 30, 2025, we have received more than 2,000 unique prescriptions and shipped to more than 1,500 patients, supported by over 600 prescribers nationwide,” said Liquidia Corp. (NASDAQ:LQDA) CEO Roger Jeffs.
“With the strong foundation established in our first full quarter post-launch, we are well positioned to pursue sustained growth and continued profitability, while thoughtfully investing in programs to expand Yutrepia’s therapeutic profile and advance L606 into pivotal trials,” he noted.
4. Upwork Inc. (NASDAQ:UPWK)
Upwork ended a four-day loss on Tuesday, surging 13.24 percent to close at $17.70 apiece as investors took heart from its impressive earnings performance and higher growth outlook for the full-year period.
In an updated report, Upwork Inc. (NASDAQ:UPWK) said it grew its net income by 6 percent in the third quarter of the year to $29.3 million from $27.7 million in the same period last year, while total revenues rose by 4 percent to $201.7 million from $193.78 million year-on-year.
Encouraged by the results, Upwork Inc. (NASDAQ:UPWK) raised its growth outlook for full-year 2025, with revenues now expected at $782 million to $787 million, versus the $765 million to $775 million projected previously.
Adjusted EBITDA outlook was also raised to a range of $222 million to $225 million from the $206 million to $214 million expected prior.
For the fourth quarter alone, Upwork Inc. (NASDAQ:UPWK) was targeting revenues to settle at $193 million to $198 million, while adjusted EBITDA was pegged at $49 million to $52 million.
“The third quarter marked the start of the next chapter for Upwork. As we build the world’s human and AI-powered work marketplace, we’re driving phenomenal user productivity and engagement, resulting in a return to positive GSV growth,” President and CEO Hayden Brown said.
“We are executing with speed and precision across our growth levers of AI, SMB, and Enterprise, and are now on the path to sustained, multi-year growth,” she noted.
3. Super Group SGHC Ltd. (NYSE:SGHC)
Super Group snapped an eight-day losing streak on Tuesday, jumping 15.62 percent to close at $12.21 apiece as investors cheered its stellar earnings performance and an upbeat growth outlook for the full-year 2025.
In an updated report, Super Group SGHC Ltd. (NYSE:SGHC) said net income attributable to shareholders in the third quarter expanded by 860 percent to $96 million from $10 million in the same period last year.
Revenues jumped by 25.7 percent to $557 million from $443 million year-on-year, driven by growth from the Africa, Europe, and North America markets, which partially offset the declines from its South and Latin America operations.
Its customer base also jumped by 18.8 percent to 5.5 million from 4.7 million year-on-year.
Following the results, Super Group SGHC Ltd. (NYSE:SGHC) raised its revenue guidance outlook for full-year 2025 to a range of $2.17 to $2.27 billion from the $2.125 to $2.2 billion previously.
Adjusted EBITDA outlook was also increased to $555 million to $565 million, versus the $550 million to $560 million prior.
2. Metsera, Inc. (NASDAQ:MTSR)
Metsera rallied to a new all-time high on Tuesday after pharmaceutical giant Novo Nordisk heated up efforts to snatch the company from Pfizer Inc. for an upsized $10 billion acquisition offer.
In intra-day trading, Metsera, Inc. (NASDAQ:MTSR) jumped to a new 52-week high of $74.24 before trimming gains to finish the day just up by 20.50 percent at $73.18 apiece.
Earlier in the day, Novo Nordisk announced that it raised its acquisition bid to acquire Metsera, Inc. (NASDAQ:MTSR) for $10 billion, which the latter declared “superior” to Pfizer’s $7 billion. It can be recalled that Pfizer already secured the approval of Metsera last month for a merger plan.
Under Novo Nordisk’s updated proposal, it would acquire all outstanding shares of Metsera, Inc. (NASDAQ:MTSR) at a price of $62.20 apiece alongside contingent value rights for up to $24 based on the achievement of certain clinical and regulatory milestones.
Pfizer on Tuesday said that it filed two lawsuits against Novo Nordisk and Metsera, Inc.’s (NASDAQ:MTSR) controlling shareholders for conspiring and breaching the agreement.
It said that Novo Nordisk’s move “constitutes an anticompetitive action … to protect its dominant market position in GLP-1s.”
“Pfizer intends to seek all appropriate remedies, including injunctive relief to ensure that Novo Nordisk’s anticompetitive proposed transaction is not permitted to move forward,” it said.
1. Hertz Global Holdings, Inc. (NASDAQ:HTZ)
Hertz Global saw its share prices jump by 36.23 percent on Tuesday to close at $6.73 apiece following an impressive earnings performance in the third quarter of the year.
In an updated report, Hertz Global Holdings, Inc. (NASDAQ:HTZ) said it swung to a net income of $184 million from a $1.3 billion net loss in the same period last year.
Adjusted EBITDA stood at $43 million, reversing a loss of $208 million in the same comparable period, primarily driven by its disciplined operational execution and improved fleet economics.
Revenues, however, were down by 4 percent to $2.48 billion from $2.58 billion year-on-year.
“This quarter proves that we’re delivering on our commitments: driving strong results through focused execution and operational discipline,” said Hertz Global Holdings, Inc. (NASDAQ:HTZ) CEO Gil West.
“Throughout this transformation, we’re rebuilding our foundation while sharpening our skills and capabilities, creating a new platform for growth. Our progress is meaningful, our heads are down, but our eyes are on the horizon as we build a company that can thrive across the full spectrum of mobility,” he noted.
While we acknowledge the potential of HTZ to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than HTZ and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge fund investor letters by entering your email below.
